Platelets and Metastasis: New Implications of an Old Interplay
During the process of hematogenous metastasis, tumor cells interact with platelets and their precursors megakaryocytes, providing a selection driver for the metastatic phenotype. Cancer cells have evolved a plethora of mechanisms to engage platelet activation and aggregation. Platelet coating of tum...
Main Authors: | Serena Lucotti, Ruth J. Muschel |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01350/full |
Similar Items
-
Detection of tissue factor in platelets: why is it so troublesome?
by: Bjarne Østerud, et al.
Published: (2019-11-01) -
Anagrelide is an anti-megakaryocytic and not an anti-platelet agent
by: Steve P. Watson, et al.
Published: (2019-01-01) -
Pathogenic Mechanisms Involved in the Hematological Alterations of Arenavirus-induced Hemorrhagic Fevers
by: Roberto G. Pozner, et al.
Published: (2013-01-01) -
High-Intensity Exercise Training Improves Basal Platelet Prostacyclin Sensitivity and Potentiates the Response to Dual Anti-Platelet Therapy in Postmenopausal Women
by: Kate A. Wickham, et al.
Published: (2022-10-01) -
Platelets and megakaryocytes /
by: Gibbins, Jonathan M., et al.
Published: (c200)